As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two ...

Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to ...

On Aug. 10, 2024, more people than ever before experienced cheers, sun and community as they joined up in Seattle and ...

Dr. Nicole Fleming, a gynecologic oncologist specializing in the treatment of gynecologic malignancies with both surgical and ...

Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...

Fred Hutch Cancer Center researchers developing immunotherapies using engineered adaptive immune system cells have received ...

As cold and flu season ramps up, the most vulnerable among us need extra protection. Infants are among the most susceptible ...

Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch Member Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch Fleischauer Family Endowed Chair ...

Dr. Andrew Cowan is a hematologist-oncologist who specializes in treating patients with multiple myeloma and other blood disorders. He leads clinical trials of new treatments for these diseases, ...

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, ...

Healthier lives for every person in every community. At Fred Hutchinson Cancer Center, we’re driven by the urgency of our patients, the hope of our community, and our passion for discovery to pursue ...

Basic science discoveries underlie the innovative cures and treatments we develop at Fred Hutch. Our research teams strive to understand the normal molecular functioning of cells as well as the ...